IGS1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - IGC Pharma Inc

Watchlist Manager

Watchlist

Price: 0.244 EUR -1.61%

Market Cap: €18.5m

	IGC Pharma Inc F:IGS1	US
A	Arrow Syndicate PCL SET:ARROW	TH
N	NR Instant Produce PCL SET:NRF	TH

Profitability Summary

IGC Pharma Inc's profitability score is 6/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

22%

Sustainable 3Y Average Gross Margin

45%

Declining Gross Margin

44% > 22%

Negative Operating Margin

-987%

Negative 3Y Average Operating Margin

-749%

Declining Operating Margin

-783% > -987%

Negative Net Margin

-702%

Negative 3Y Average Net Margin

-773%

Net Margin is Increasing

-801% > -702%

Negative Free Cash Flow Margin

-609%

Negative 3Y Average Free Cash Flow Margin

-509%

Declining Free Cash Flow Margin

-513% > -609%

Negative ROE

-129%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-101%

Declining ROIC

-77% > -157%

View All

Hide

Collapse

6 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.